Arkolith/Insider Trading/EPIX/Form 4

Virsik Peter

Chief Operating OfficerESSA Pharma Inc. (EPIX) · full profile →Form 4 · filed Feb 6, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 5, 2024Sell(S)500$10.04$5K13K
Feb 5, 2024Option exercise(M)500$3.23$2K14K
Feb 5, 2024Sell(S)694$9.25$6K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 5, 2024Option exercise(M)500—$0968K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-002881) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML